Skip to content

Small UK study suggests that depression does not have an impact on hepatitis C treatment outcomes in people co-infected with HIV

Adherence to hepatitis C treatment: unravelling the complexities

Hepatitis C patients with cirrhosis respond well to boceprevir or telaprevir with careful monitoring

Christophe Hézode, Hôpital Henri Mondor, Paris.  © Liz Highleyman / hivandhepatitis.com

Reducing ribavirin and adding EPO are both good anaemia management strategies for people taking boceprevir

Eric Lawitz from Alamo Medical Research, Texas © Liz Highleyman / hivandhepatitis.com

Abbott interferon-free combination 'promising' in harder-to-treat patients with hepatitis C

Kris Kowdley, Liver Center of Excellence at Virginia Mason Medical Center, Seattle © Liz Highleyman / hivandhepatitis.com

European guidelines on management of mental health for people with hepatitis C published

Hepatitis C drug alisporivir is effective, but pancreatitis a concern

Hepatitis C drug alisporivir is effective, but pancreatitis a concern

Telaprevir and boceprevir show high rate of serious side-effects in hepatitis C patients with urgent need of treatment

Interferon-lambda as effective as alpha but with much better safety profile in hepatitis C